Impact BioMedical Inc. (IBO)

Market Cap	17.82M
Revenue (ttm)	n/a
Net Income (ttm)	-4.25M
Shares Out	11.50M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,962
Open	1.510
Previous Close	1.573
Day's Range	1.450 - 1.637
52-Week Range	1.230 - 3.000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 23, 2024

About IBO

Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a s...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Sep 16, 2024
• Employees: 1
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: IBO
• Website: https://www.impactbiomedinc.com